BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen WM, Chiang JC, Lin YC, Lin YN, Chuang PY, Chang YC, Chen CC, Wu KY, Hsieh JC, Chen SK, Huang WP, Chen BPC, Lee H. Lysophosphatidic acid receptor LPA3 prevents oxidative stress and cellular senescence in Hutchinson-Gilford progeria syndrome. Aging Cell 2020;19:e13064. [PMID: 31714004 DOI: 10.1111/acel.13064] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Vehns E, Arnold R, Djabali K. Impact of MnTBAP and Baricitinib Treatment on Hutchinson–Gilford Progeria Fibroblasts. Pharmaceuticals 2022;15:945. [DOI: 10.3390/ph15080945] [Reference Citation Analysis]
2 Ren T, Lin W, He S, Yang X, Xian M, Zhang Z, Luo W, Nie Q, Zhang X. Integrative Analysis of Metabolomic and Transcriptomic Data Reveals the Antioxidant Potential of Dietary Lutein in Chickens. Front Vet Sci 2022;9:906853. [DOI: 10.3389/fvets.2022.906853] [Reference Citation Analysis]
3 Mosevitsky MI. Progerin and Its Role in Accelerated and Natural Aging. Mol Biol 2022;56:125-46. [DOI: 10.1134/s0026893322020091] [Reference Citation Analysis]
4 Hamsanathan S, Gurkar AU. Lipids as Regulators of Cellular Senescence. Front Physiol 2022;13:796850. [DOI: 10.3389/fphys.2022.796850] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Chiang J, Chen W, Newman C, Chen BPC, Lee H. Lysophosphatidic Acid Receptor 3 Promotes Mitochondrial Homeostasis against Oxidative Stress: Potential Therapeutic Approaches for Hutchinson–Gilford Progeria Syndrome. Antioxidants 2022;11:351. [DOI: 10.3390/antiox11020351] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wijaya YT, Setiawan T, Sari IN, Nah SY, Kwon HY. Amelioration of muscle wasting by gintonin in cancer cachexia. Neoplasia 2021;23:1307-17. [PMID: 34798386 DOI: 10.1016/j.neo.2021.11.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Liu W, Hopkins AM, Hou J. The development of modulators for lysophosphatidic acid receptors: A comprehensive review. Bioorg Chem 2021;117:105386. [PMID: 34695732 DOI: 10.1016/j.bioorg.2021.105386] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Choi JH, Oh J, Lee MJ, Bae H, Ko SG, Nah SY, Cho IH. Inhibition of lysophosphatidic acid receptor 1-3 deteriorates experimental autoimmune encephalomyelitis by inducing oxidative stress. J Neuroinflammation 2021;18:240. [PMID: 34666785 DOI: 10.1186/s12974-021-02278-w] [Reference Citation Analysis]
9 Jin Y, Kim EN, Lim JH, Kim HD, Ban TH, Yang CW, Park CW, Choi BS. Role of Aberrantly Activated Lysophosphatidic Acid Receptor 1 Signaling Mediated Inflammation in Renal Aging. Cells 2021;10:2580. [PMID: 34685560 DOI: 10.3390/cells10102580] [Reference Citation Analysis]
10 Fafián-Labora JA, Morente-López M, de Toro FJ, Arufe MC. High-Throughput Screen Detects Calcium Signaling Dysfunction in Hutchinson-Gilford Progeria Syndrome. Int J Mol Sci 2021;22:7327. [PMID: 34298947 DOI: 10.3390/ijms22147327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Pils V, Terlecki-Zaniewicz L, Schosserer M, Grillari J, Lämmermann I. The role of lipid-based signalling in wound healing and senescence. Mech Ageing Dev 2021;198:111527. [PMID: 34174292 DOI: 10.1016/j.mad.2021.111527] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Solís KH, Romero-Ávila MT, Guzmán-Silva A, García-Sáinz JA. The LPA3 Receptor: Regulation and Activation of Signaling Pathways. Int J Mol Sci 2021;22:6704. [PMID: 34201414 DOI: 10.3390/ijms22136704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Meduri B, Pujar GV, Durai Ananda Kumar T, Akshatha HS, Sethu AK, Singh M, Kanagarla A, Mathew B. Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development. Eur J Med Chem 2021;222:113574. [PMID: 34126459 DOI: 10.1016/j.ejmech.2021.113574] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Hu D, Yuan S, Zhong J, Liu Z, Wang Y, Liu L, Li J, Wen F, Liu J, Zhang J. Cellular senescence and hematological malignancies: From pathogenesis to therapeutics. Pharmacol Ther 2021;223:107817. [PMID: 33587950 DOI: 10.1016/j.pharmthera.2021.107817] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Lee SC, Lin KH, Balogh A, Norman DD, Bavaria M, Kuo B, Yue J, Balázs L, Benyó Z, Tigyi G. Dysregulation of lysophospholipid signaling by p53 in malignant cells and the tumor microenvironment. Cell Signal 2021;78:109850. [PMID: 33253914 DOI: 10.1016/j.cellsig.2020.109850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Chiang JC, Chen WM, Lin KH, Hsia K, Ho YH, Lin YC, Shen TL, Lu JH, Chen SK, Yao CL, Chen BPC, Lee H. Lysophosphatidic acid receptors 2 and 3 regulate erythropoiesis at different hematopoietic stages. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158818. [PMID: 33035680 DOI: 10.1016/j.bbalip.2020.158818] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Ma Q, Liang M, Cai T, Yu Y, Liang X, Chen Q, Du M, Ouyang Y, Chen C, Cai Y. Protective Effect of Shenqi Maixintong Capsule against ox-LDL-Induced Injury in RAW264.7 Macrophages. Evidence-Based Complementary and Alternative Medicine 2020;2020:1-12. [DOI: 10.1155/2020/6708152] [Reference Citation Analysis]
18 Lin YN, Audira G, Malhotra N, Ngoc Anh NT, Siregar P, Lu JH, Lee H, Hsiao CD. A Novel Function of the Lysophosphatidic Acid Receptor 3 (LPAR3) Gene in Zebrafish on Modulating Anxiety, Circadian Rhythm Locomotor Activity, and Short-Term Memory. Int J Mol Sci 2020;21:E2837. [PMID: 32325720 DOI: 10.3390/ijms21082837] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
19 Chen WM, Chiang JC, Lin YC, Lin YN, Chuang PY, Chang YC, Chen CC, Wu KY, Hsieh JC, Chen SK, Huang WP, Chen BPC, Lee H. Lysophosphatidic acid receptor LPA3 prevents oxidative stress and cellular senescence in Hutchinson-Gilford progeria syndrome. Aging Cell 2020;19:e13064. [PMID: 31714004 DOI: 10.1111/acel.13064] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]